Misclassification and discordance of measured blood pressure from patient's true blood pressure in current clinical practice: A clinical trial simulation case study

Journal of Pharmacokinetics and Pharmacodynamics

Volumn 39, Issue 3, 2012, Pages 283-294

  Jin, Yuyan ^a   Bies, Robert ^b   Gastonguay, Marc R ^c   Stockbridge, Norman ^d   Gobburu, Jogarao ^e   Madabushi, Rajanikanth ^d  

^a PFIZER INC   (United States)

^b INDIANA UNIVERSITY   (United States)

^c Metrum Institute   (United States)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Blood pressure calibration; Blood pressure misclassification; Circadian rhythm; Hypertension; Modeling and simulation; Public health; Sphygmomanometer

Indexed keywords

AMLODIPINE; AMLODIPINE PLUS VALSARTAN; ANTIHYPERTENSIVE AGENT; CLONIDINE; MOXONIDINE; NIFEDIPINE; NITRENDIPINE; TELMISARTAN;

ACCURACY; ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CALIBRATION; CIRCADIAN RHYTHM; CLINICAL PRACTICE; COMPUTER MODEL; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONTE CARLO METHOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; SIMULATION; SPHYGMOMANOMETER;

BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; COMPUTER SIMULATION; DATABASES, FACTUAL; HUMANS; MONTE CARLO METHOD;

EID: 84865491867     PISSN: 1567567X     EISSN: 15738744     Source Type: Journal    
DOI: 10.1007/s10928-012-9250-8     Document Type: Article

References (31)

1. Egan BM, Zhao Y, Axon RN (2010) US trends in prevalence, awareness, treatment, and control of hypertension 1988-2008. JAMA 303:2043-2050
2. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS (2007) Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 49:69-75
3. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB (2008) General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117:743-753
4. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ (2003) The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289:2560-2572
5. Bennett S (1994) Blood pressure measurement error: its effect on cross-sectional and trend analyses. J Clin Epidemiol 47:293-301
6. Hart CL, Hole DJ, Davey Smith G (2001) Are two really better than one? Empirical examination of repeat blood pressure measurements and stroke risk in the Renfrew/Paisley and collaborative studies. Stroke 32:2697-2699
7. Marshall T (2004) When measurements are misleading: modelling the effects of blood pressure misclassification in the English population. BMJ 328:933
8. Marshall T (2006) Misleading measurements: modeling the effects of blood pressure misclassification in a United States population. Med Decis Making 26:624-632
9. Marshall T, Rouse A (2001) Blood pressure measurement. Doctors who cannot calibrate sphygmomanometers should stop taking blood pressures. BMJ 323:806
10. Neufeld PD, Johnson DL (1986) Observer error in blood pressure measurement. CMAJ 135:633-637
11. Rouse A, Marshall T (2001) The extent and implications of sphygmomanometer calibration error in primary care. J Hum Hypertens 15:587-591
12. Spranger CB, Ries AJ, Berge CA, Radford NB, Victor RG (2004) Identifying gaps between guidelines and clinical practice in the evaluation and treatment of patients with hypertension. Am J Med 117:14-18
13. Turner MJ, Baker AB, Kam PC (2004) Effects of systematic errors in blood pressure measurements on the diagnosis of hypertension. Blood Press Monit 9:249-253
14. Turner MJ, Irwig L, Bune AJ, Kam PC, Baker AB (2006) Lack of sphygmomanometer calibration causes over- and under-detection of hypertension: a computer simulation study. J Hypertens 24:1931-1938
15. Waugh JJ, Gupta M, Rushbrook J, Halligan A, Shennan AH (2002) Hidden errors of aneroid sphygmomanometers. Blood Press Monit 7:309-312
16. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ (2005) Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation 111:697-716
17. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves JW, Hill MN, Jones DH, Kurtz T, Sheps SG, Roccella EJ (2005) Recommendations for blood pressure measurement in humans: an AHA scientific statement from the Council on High Blood Pressure Research Professional and Public Education Subcommittee. J Clin Hypertens (Greenwich) 7:102-109
18. Hempel G, Karlsson MO, de Alwis DP, Toublanc N, McNay J, Schaefer HG (1998) Population pharmacokinetic-pharmacodynamic modeling of moxonidine using 24-hour ambulatory blood pressure measurements. Clin Pharmacol Ther 64:622-635
19. Parati G, Vrijens B, Vincze G (2008) Analysis and interpretation of 24-h blood pressure profiles: appropriate mathematical models may yield deeper understanding. Am J Hypertens 21:123-125 discussion 127-129
20. Head GA, Reid CM, Shiel LM, Jennings GL, Lukoshkova EV (2006) Rate of morning increase in blood pressure is elevated in hypertensives. Am J Hypertens 19:1010-1017
21. Hui Kimko SBD (2002) Simulation for designing clinical trial: pharmacokinetic and pharmacodynamic modeling perspective. Drugs Pharm Sci 127. Accessed July 2011
22. Gibiansky L, Gastonguay MR (2006) R/NONMEM toolbox for simualtion from posterior parameter (uncertainty) distributions. The Population Approach Group in Europe: Abstract 958
23. Mondick JT, Gibiansky L, Gastonguay MR, Veal GJ, Barrett JS (2006) Acknowledging parameter uncertainty in the simulationbased design of an actinomycin-D Pharmacokinetic Study in pediatric patients with Wilms' tumor or rhabdomyosarcoma. The Population Approach Group in Europe: Abstract 938
24. Asmar R, Safar M, Queneau P (2001) Evaluation of the placebo effect and reproducibility of blood pressure measurement in hypertension. Am J Hypertens 14:546-552
25. Jones DW, Appel LJ, Sheps SG, Roccella EJ, Lenfant C (2003) Measuring blood pressure accurately: new and persistent challenges. JAMA 289:1027-1030
26. Jones JS, Ramsey W, Hetrick T (1987) Accuracy of prehospital sphygmomanometers. J Emerg Med 5:23-27
27. Idema RN, Gelsema ES, Wenting GJ, Grashuis JL, van den Meiracker AH, Brouwer RM, Man in 't Veld AJ (1992) A new model for diurnal blood pressure profiling. Square wave fit compared with conventional methods. Hypertension 19:595-605
28. Head GA, Chatzivlastou K, Lukoshkova EV, Jennings GL, Reid CM (2010) A novel measure of the power of the morning blood pressure surge from ambulatory blood pressure recordings. Am J Hypertens 23:1074-1081
29. Head GA, Reid CM, Lukoshkova EV (2005) Nonsymmetrical double logistic analysis of ambulatory blood pressure recordings. J Appl Physiol 98:1511-1518
30. Muneta S, Kohara K, Hiwada K (1999) Effects of benidipine hydrochloride on 24-hour blood pressure and blood pressure response to mental stress in elderly patients with essential hypertension. Int J Clin Pharmacol Ther 37:141-147
31. Hanninen MR, Niiranen TJ, Puukka PJ, Mattila AK, Jula AM (2011) Determinants of masked hypertension in the general population: the Finn-Home study. J Hypertens 29:1880-1888